Teva Pharmaceutical Industries Ltd (TEVJF) Amortization of Goodwill (2017 - 2024)

Teva Pharmaceutical Industries' (TEVJF) quarterly Amortization of Goodwill came in at $280.0 million in Q4 2024, down 53.33% on a QoQ basis from $600.0 million in Q3 2024.

Teva Pharmaceutical Industries Ltd (TEVJF) Amortization of Goodwill (2017 - 2024) Analysis & Trends

Teva Pharmaceutical Industries (TEVJF) has 3 years of Amortization of Goodwill data on file, last reported at $280.0 million in Q4 2024.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $280.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $280.0 million (down 78.12% YoY) and the FY2024 annual result came in at $1.3 billion, up 82.86% from the prior year.
  • Amortization of Goodwill eased to $280.0 million in Q4 2024, from $600.0 million in the prior quarter.
  • In the past five years, Amortization of Goodwill ranged from a high of $600.0 million in Q3 2024 to a low of $280.0 million in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2024 280.00 Mn
Dec 31, 2024 280.00 Mn
Sep 30, 2024 600.00 Mn
Sep 30, 2024 600.00 Mn
Jun 30, 2024 400.00 Mn
Jun 30, 2024 400.00 Mn
Jun 30, 2018 120.00 Mn
Jun 30, 2018 120.00 Mn
Mar 31, 2018 180.00 Mn
Mar 31, 2018 180.00 Mn
Jun 30, 2017 6.10 Bn
Jun 30, 2017 6.10 Bn